Objective. To develop and validate an assessment tool, based on the 'Royal College of General Practitioners' (RCGP) Video Assessment Tool', for assessment of pharmacist prescribers' consultation skills.
Introduction
Many developments in pharmacy practice in the UK have taken place recently. Pharmacist prescribing, initially introduced as supplementary prescribing in 2003, followed by independent prescribing in 2006, 1, 2 is one of the most notable developments.
The scope of independent prescribing, described as 'prescribing by a practitioner responsible and accountable for the assessment of patients with undiagnosed or diagnosed conditions and for decisions about the clinical management required, including prescribing', is wide ranging. All licensed medicines (other than controlled drugs) can be prescribed within the independent prescriber's competence with no need for any overarching endorsement by a medical practitioner. 3 Qualification as an independent pharmacist prescriber requires completion of a short postgraduate course. This comprises 26 days of university delivered training, with an additional 12 days in practice under the guidance of a designated medical practitioner. 4 To date, 1600 pharmacists in Great Britain have completed their prescribing training and are registered with the Royal Pharmaceutical Society of Great Britain as prescribers.
Consultation skills are a key element of this training, aiming to further develop effective relationships and communication strategies and to demonstrate a shared approach to decision making. 4 Despite the emphasis placed on consultation skills during training, the published literature on pharmacist prescribers' consultation skills training or practice is sparse. Cleland et al. used semi-structured interviews with a purposive sample of nine prescribers to explore views of consultation skills training and impact on practice. While participants were positive about their enhanced skills, some practical difficulties were highlighted. 5 Most patient-focused research relates to patients' perspectives of pharmacist prescribing or their satisfaction with prescribing services, rather than consultation skills. [6] [7] [8] Consultation skills are recognized as a central component of the clinical encounter. A recent patient survey reported by the General Medical Council identified communication skills as the second most influential factor (after giving good advice and treatment) in patients' confidence in their doctors. 9 Studies involving doctors have also demonstrated key benefits, including enhanced working relationships, increased patient satisfaction and improved health outcomes. [10] [11] [12] Several consultation skills assessment tools are available for medical consultations, including the 'Segue framework', 13 ' Henbest and Stewart rating scale' 14 and the 'Royal College of General Practitioners' (RCGP) summative assessment single route video assessment. 15 Of these, the latter has contributed both formatively and summatively to the assessment process for membership of the RCGP. Each consultation is assessed around five broad areas of discovering the reason for the patient's attendance, defining the clinical problem(s), explaining the problem(s) to the patient, addressing the patient's problem(s) and making effective use of the consultation. The application and concurrent validity of this tool have been previously described. 16, 17 As with the medical consultation, evaluation of pharmacist prescribers' consultation skills is critical. However, there is no validated tool for either formative or summative assessment of pharmacist prescribers' consultation skills. Greenwood et al. 18 reported one study in which they used the Henbest and Stewart rating scale (assesses patient-centredness) 14 and the Segue framework (assesses content of the consultation). 13 Salter et al. 19 have used discourse analysis to research pharmacist consultations. Both studies had limitations and neither validated an evaluation tool or approach.
Thus, the aim of our study was to develop and validate a tool based on the RCGP video assessment tool for assessment of pharmacist prescribers' consultations.
Methods

Development of the scale
The five competency areas of the RCGP video assessment tool were left unchanged. Performance criteria (PC) for each of the competency areas were modified to reflect the pharmacist prescribing context by replacing the term 'doctor' with 'pharmacist prescriber' and placing less emphasis on physical and mental examination and clinical diagnosis. Each criterion was rated on a scale of 1 (poor) to 5 (excellent) with the option of scoring 'not observed'. In addition, there was an overall rating for the consultation and space for free text comments on specific strengths, weaknesses and serious concerns.
The tool was further refined by a panel of four GP assessors with extensive training and experience in video assessment of medical consultations and six academics with expertize in medical and pharmacy education. The panel communicated by email apart from one face to face meeting when face and content validity of the tool were established by consensus.
Sample of pharmacist prescribers and recruitment
A purposive sample of 10 study sites was identified. These were selected to provide a range of geographical regions, practice settings (community pharmacy, general practice and hospital) and therapeutic areas of prescribing (cardiovascular, diabetes, oncology, pain and respiratory). To participate, each pharmacist had to have been prescribing for at least 20 patients in the previous 3 months. Pharmacists were approached sequentially to recruit the sample of 10. Written informed consent was obtained from each pharmacist. Each pharmacist identified, recruited and consented two patients. There were no exclusion criteria.
Data collection
One consultation between each of the recruited patients and their pharmacist prescriber was video recorded. The Guidance of the General Medical Council on video recording was followed. Video recording was undertaken by a researcher, except in three cases where pharmacists undertook the recording themselves, following detailed verbal and written instructions. The pharmacists were informed that the video recordings would be reviewed by experts but were not given any details regarding the content of the assessment tool.
Each recording was assessed independently by two randomly assigned GP assessors (from the panel of four who had contributed to tool development) using the new scale. Data were analysed for completeness, and inter-rater reliability (agreement between assessors) was tested using intraclass correlation coefficient (ICC).
Construct validity was assessed by comparing assessor scores with a patient satisfaction score based on a validated scale, 20 which had been adapted and used previously for pharmacist prescriber consultations. 7 Questions relating to in-depth examination and longterm professional relationships were removed from Baker's scale leaving nine statements rated on a 5point Likert scale. The scale was completed by each patient immediately after the consultation. Spearman's rho was used to test the correlations between the two assessor scores and the patient satisfaction score.
Approval for the research was obtained from the Multi-Centre Research Ethics Committee for Scotland and the relevant Research and Development committees in Scotland.
Results
The RCGP tool was modified to give the Pharmacist Consultation Assessment Tool (PharmaCAT). The RCGP tool and PharmaCAT are compared in Table 1 . PharmaCAT 4. . . . and undertakes appropriate assessment of the patient's condition systematically 6. The physical/mental examination chosen is likely to confirm or disprove hypotheses that could reasonably have been formed; Or is designed to address a patient's concern PharmaCAT 5. The pharmacist obtains sufficient information to be aware of other/suspected new diagnoses beyond the scope of management, or diagnosis, and refers to appropriate medical professional or other health professional, if necessary 5. The doctor obtains sufficient information to include or exclude likely relevant significant conditions 7. The doctor appears to make a clinically appropriate working diagnosis PharmaCAT 6. The pharmacist explains the clinical condition in appropriate language 8. The doctor explains the problem or diagnosis in appropriate language PharmaCAT 7. The pharmacist explanation incorporates some or all of the patient's health beliefs 9. The doctor specifically seeks to confirm the patient's understanding of the diagnosis PharmaCAT 10. The pharmacist specifically seeks to confirm the patient's understanding of any newly diagnosed conditions and management PharmaCAT 8. The management plan (including any prescription) is appropriate for the clinical reason/working diagnosis, reflecting a good understanding of modern accepted clinical practice 10. The management plan (including any prescription) is appropriate for the working diagnosis, reflecting a good understanding of modern accepted medical practice PharmaCAT 9. The patient is given the opportunity to be involved in significant management decisions to enhance concordance 11. The patient is given the opportunity to be involved in significant management decisions Nineteen pharmacists were approached to recruit the sample of 10. These 10 were from six National Health Service (NHS) organizational areas in Scotland (see Table 2 ). Pharmacists' performances on each of the 12 criteria are given in Table 3 . The median overall rating was 3 (range 1-4) on a scale of 1 (poor) to 5 (excellent). There was good agreement between the two assessors for the total PharmaCAT (sum of scores of PC1-PC12) scores (ICC = 0.694).
Pharmacists performed best in PC1 (encourage the patient's contribution at appropriate points in the consultation), PC9 (management plan is appropriate for the clinical reason/working diagnosis) and PC12 (specifies the conditions and interval for follow-up or review).
Lower scores were obtained for PC5 (obtains sufficient information to rule out any medical condition beyond their scope of management), PC7 (explanation incorporates some or all of the patient's health beliefs), PC8 (specifically seeks to confirm the patient's understanding of the clinical condition/diagnosis) and PC10 (specifically seeks to confirm the patient's understanding of the clinical condition/diagnosis). There were 10 occurrences of 'not observed' for PC 7 (patient's health beliefs).
Fourteen patient satisfaction questionnaires were returned (see Table 4 ) and almost all (n = 13, 93%) agreed or strongly agreed that they were entirely satisfied with the consultation.
Spearman's rho, measuring correlation between total PharmaCAT scores for the two assessors and total patient satisfaction scores, indicated little correlation (rho = 0.142 and 0.242).
Discussion
In this study, we developed and tested PharmaCAT, modified from the RCGP video assessment tool. The tool had discriminatory power between pharmacist prescribers and the different competency areas and inter-rater reliability. However, there was little correlation between assessors' total PharmaCAT scores and patients' ratings of consultation satisfaction. Similarly, McKinstry et al. 21 showed little correlation between the RCGP tool and patients' scores on a consultation satisfaction questionnaire. While patients' views on satisfaction are valuable, they may be measuring something different and additional to the skills of the practitioner linked to other competencies. They may also be a poor measure of discrimination.
Our research has strengths and weaknesses. To our knowledge, this is the first study assessing pharmacist consultations using a set of criteria covering specific competency areas. We studied a range of settings and specialities and importantly benchmarked pharmacist prescribing consultations using a tool modified from one developed for trainee GP. We used experienced RCGP consultation skills assessors with many years of experience for testing the reliability of the PharmaCAT. Our consultations were video recorded rather than audio taped in order to examine nonverbal as well as verbal communication. Limitations included the small sample numbers of pharmacists and patients and the lack of representation from secondary care settings. There was potential for selection bias as the participating pharmacists recruited the patients; however, this is similar to the process used by the RCGP.
Pharmacists' performances varied across the criteria. Higher scores were obtained in relation to encouraging the patient's contribution and aspects of clinical management with lower scores for achieving concordance and exploring patient health beliefs. Areas of lower scores and omissions may reflect the pharmacists' prior knowledge and management of the patient or their lack of familiarity with the assessment tool. In future, the assessment criteria should be embedded in the training programme and pharmacists made aware of the need to focus on all aspects of the consultation assessment criteria, regardless of their familiarity with the patient. The development of PharmaCAT using video recordings is a clear advance. Previous studies from Greenwood et al. 18 and Salter et al. 19 were based on audio recordings. Greenwood studied six pharmacists' interactions with 18 congestive cardiac failure patients. Although none of the pharmacists were registered prescribers, they were expected to explore patients' understanding of heart failure, strategies for self-management, undertake a medication review and provide lifestyle advice. The authors concluded that the Henbest and Stewart rating scale (assesses patient-centredness) 14 and the Segue framework (assesses content of the consultation) 13 were appropriate for assessing audio recording of pharmacist consultations. However, they also noted the limitations of audio recording including the inability to record visual information.
Salter et al. 19 used discourse analysis to explore the advice giving role of pharmacists (non-prescribers) during consultation for medication review with patients aged 80 years and above. One researcher observed, taped and transcribed a total of 29 consultations with seven pharmacists. Although the pharmacists provided advice, this was rarely initiated by the patients and often resisted or rejected.
The RCGP video assessment tool has recently been modified to be used in a more formative way as part of work-based assessment, the 'Consultation Observation Tool'. 22 This has the same competency areas as before but each is now graded on a four-point scale of 'insufficient evidence', 'needs further development', 'competent' and 'excellent'. We now note that the potential of adopting this scale for PharmaCAT, subject to confirmation of validity and reliability.
Further work is required to test PharmaCAT with a greater number of pharmacists in more diverse therapeutic areas. There may also be a role for a summative assessment tool for pharmacist prescribers based on PharmaCAT. PharmaCAT was developed for pharmacist prescribers but we suggest that with a similar process of modification and validation, a further modified tool may be applicable to all non-medical prescribers, including nurses, physiotherapists and optometrists.
